secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001641172-25-015349
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health terminates CEO Deepika Vuppalanchi for cause; CFO appointed interim CEO
--------------------------------------------------------------------------------

- Board terminated CEO Deepika Vuppalanchi for cause on June 13, 2025.
- Priya Prasad, previously CFO and COO, appointed interim CEO effective June 16, 2025.
- Termination of employment agreement dated April 5, 2021 for cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225015349/0001641172-25-015349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225015349/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer